Related Experiment Video
Updated: Jul 11, 2026
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Candidate genes for the progression of malignant gliomas identified by microarray analysis
Oliver Bozinov1, Sylvia Köhler, Birgit Samans
1Department of Neurosurgery, Philipps-University Marburg, Baldingerstrasse, 35033 Marburg, Germany. bozinov@med.uni-marburg.de
Neurosurgical Review
|October 6, 2007
Summary
This study identified 166 gene alterations in malignant astrocytomas, revealing Olig2 and IL-13Ralpha2 as key genes in tumor progression. These findings advance understanding of glioma molecular basis.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genomics
Background:
- Malignant astrocytomas (WHO grade III/IV) have poor prognoses, with limited understanding of their molecular progression.
- Identifying molecular drivers is crucial for developing targeted therapies for these aggressive brain tumors.
Purpose of the Study:
- To compare the transcriptional profiles of anaplastic astrocytomas (WHO grade III) and glioblastomas (WHO grade IV) using microarray analysis.
- To identify differentially expressed genes that may play a role in the malignant progression of astrocytomas.
Main Methods:
- Microarray analysis of 4,608 genes in tumor samples from 15 patients (6 anaplastic astrocytomas, 9 glioblastomas).
- Validation of selected gene expression using real-time reverse transcription-polymerase chain reaction.
- Statistical analysis to identify significant gene alterations (fold change ≥ 2, |t| ≥ 1.96).
Main Results:
- Identified 166 gene alterations with significant differences in mRNA levels between the two glioma groups.
- Confirmed differential expression of Olig2 and IL-13Ralpha2 in anaplastic astrocytomas compared to glioblastomas.
- Olig2 and IL-13Ralpha2 were identified as candidate genes potentially involved in astrocytoma malignant progression.
Conclusions:
- Microarray analysis effectively identified candidate genes associated with malignant astrocytoma progression.
- Differential expression of Olig2 and IL-13Ralpha2 likely contributes to the progression from anaplastic astrocytoma to glioblastoma.
- Further investigation of these candidate genes is warranted for potential therapeutic targeting.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...